In a makeshift laboratory at the Mongbwalu general referral hospital, deep in a mining settlement in northeastern Ituri, a quiet hum now signals a shift in the fight against Ebola. The source is a compact machine called the RadiOne platform, which can deliver a molecular diagnosis of the Bundibugyo virus in less than one hour. In this landlocked region where laterite roads snake through hills and villages hit by the outbreak, every hour can mean the difference between life and death.
From a 2,000 kilometer gamble to same day results
Until a few weeks ago, every suspected sample from this area had to begin a long and uncertain journey to Kinshasa, more than 2,000 kilometers away, under precarious conditions. Conservation constraints and transport delays meant results arrived slowly, leaving medical teams in the dark and slowing decisions. Now, with diagnostic testing decentralized, analyses are done close to the communities where patients live. Results come back the same day. This change has made the health response faster, more reliable, and far more effective.
Four technicians and a portable machine that changes everything
At Mongbwalu, four laboratory technicians have been trained with support from the World Health Organization in biosafety protocols, sample handling, and operation of the RadiOne platform. Their goal is to make the lab quickly self sufficient. In Bunia, the capital of Ituri province where the platform was recently deployed, the first results are already visible. Neema Sindani, a public health laboratory technician in Bunia, said that although her team does not have direct contact with patients, their contribution is decisive. Thanks to the innovative and easy to use solution, results are now available in just one hour, allowing medical teams to intervene earlier with confirmed cases and increase patients' chances of survival.
Why this matters in a remote outbreak zone
The deployment of this technology was supported by the United Kingdom Foreign, Commonwealth and Development Office, in partnership with the World Health Organization, the World Bank, the National Institute of Public Health, the National Institute of Biomedical Research, and Congolese health authorities. Together they bet on proximity diagnostics, bringing testing as close as possible to affected communities to break transmission chains at the heart of the epidemic. Dr. Olga Ntumba Tshitenge, a laboratory diagnosis and epidemic response expert at the WHO office in Kinshasa, noted that this is not the first rapid diagnostic technology used in the DRC, but in the specific context of the Bundibugyo Ebola outbreak it represents a major advance. The equipment is lightweight, easily transportable, usable without heavy infrastructure, and accessible after short training. All of these are essential for intervening in remote areas. Another critical point: the GeneXpert cartridges adapted for this strain are not yet available in the DRC, making the RadiOne platform a vital alternative in this outbreak.
